Institutional members access full text with Ovid®

Share this article on:

Estimating the size of key populations: current status and future possibilities

Abdul-Quader, Abu S.; Baughman, Andrew L.; Hladik, Wolfgang

Current Opinion in HIV and AIDS: March 2014 - Volume 9 - Issue 2 - p 107–114
doi: 10.1097/COH.0000000000000041
EPIDEMIOLOGY: CONCENTRATED EPIDEMICS: Edited by Chris Beyrer, Stefan D. Baral, and Patrick S. Sullivan

Purpose of review Estimation of key population sizes is essential for advocacy, program planning, and monitoring of HIV epidemics in these populations. A review of recent publications on population size estimation among key populations including MSM, people who inject drugs, and male and female sex workers was conducted to identify and assess current practices at the global level.

Recent findings Studies have used multiple methods including capture–recapture, service multiplier, and unique object multiplier. Other studies apply census and enumeration, often before implementation of a behavioral survey. Network scale-up is used infrequently. Newer methods or variations of existing size estimation methods have emerged that are applied solely within surveys.

Summary A range of size estimation methods is available. All methods rely on theoretical assumptions that are difficult to meet in practice, are logistically difficult to conduct, or have yet to be fully validated. Accurate and valid key population size estimates remain as necessary as they are challenging to undertake; the concurrent use of multiple methods may be justified to facilitate the triangulation and interpretation of the resulting estimates. Formative assessment can help inform the appropriateness and feasibility of different size estimation methods.

Division of Global HIV/AIDS, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Correspondence to Abu S. Abdul-Quader, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, 1600 Clifton Road, MS-E30, Atlanta, GA 30333, USA. Tel: +1 404 639 4505; e-mail: afa3@cdc.gov

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.